Insight Article Desktop Banner
 
 
Market Insights
  •  
March 15, 2022

The Pick of Private Equity: Single-Asset Secondaries

Insight Video Mobile Banner
 
March 15, 2022

The Pick of Private Equity: Single-Asset Secondaries


Market Insights

The Pick of Private Equity: Single-Asset Secondaries

Share Icon

March 15, 2022

 
 

The GP-led secondary market has witnessed a brisk pace of growth in the past two decades with a flurry of transactions in recent years. In 2021, GP-led secondaries represented 51% of the $135 billion overall secondaries market, a record year in deal volume. 1 Forecasts suggest another banner year in 2022, with deal volume expected to rise as much as 20% year on year.2 In this Q&A, Nash Waterman, Portfolio Manager and Head of Private Markets Secondaries, discusses the growing opportunity set for General Partner (GP) led deals, spelling out why we believe the sector and the single-asset segment, in particular, are attracting growing investor interest.

 
 

Where did GP-led secondaries start?
NASH WATERMAN (NW)
: Like the wider secondaries market, GP-led deals were designed to solve a problem. In the early 2000s, financial groups needed to spin out of banks and GP-led secondaries became an efficient way to lift out these assets and teams. From there, the market evolved quickly, as the suitability of GP-led deals for use in other situations quickly became apparent.

Today, single-asset transactions are the fastest growing area of the secondaries segment. The deals are gaining favor, as they provide existing GP and Limited Partner (LP) investors the ability to double down on their best portfolio assets or for LPs to take liquidity, while opening up access to outside investors without the need for highly competitive bidding processes.

At which point did you notice a divergence from the LP-led secondaries market?
NW
: In the early 2010s, GP-led secondaries experienced exponential growth driven by post-crisis fund restructurings. With the deals evolving into highly bespoke solutions, we became skilled in the more customized and surgical approach these type of transactions require. 

We began structuring deals to lift out the specific assets that we found to be the most compelling. Unlike traditional LP-led deals, or multi-asset GP-led deals for that matter, where secondaries investments involve exposure to multiple assets at the portfolio level, this new approach allowed us to mitigate unwanted broader portfolio risk. Fast-forward to today and the single-asset model now stands as a functionally distinct segment of the secondaries market. 

Early on, however, these deals were a novel concept and we had to convince GPs that single-asset deals could help to maximize value. To start, we oriented the conversation toward problem solving. For instance, we would ask, “Do you need a solution that brings in fresh capital?” or “Do you need more time to compound value for a prize asset?” Oftentimes, that potential value would be sacrificed due to a lack of funds or premature exit. Single-asset deals open the way to unlock that additional value, which is a key reason we coined the term “transformational secondaries” back before a standard nomenclature existed for these transactions. 

Why are GP-led secondaries so attractive to investors?
NW
: In our view, the sector offers the best access to top-quality assets in the middle market. Consider, too, that within private equity the penetration of secondaries activity is relatively low. In practice, this has tilted purchasing power toward buyers as primary deal activity has outstripped secondaries demand, creating a growing universe of investable assets.

As a result, managers such as ourselves can be highly selective and intentional about adding positions to the portfolio and managing risk. Put simply, we are able to cherry pick the best assets in an opportunity set of holdings that GPs view as the most attractive companies in their portfolios.

Relative to other segments of the secondaries market, single-asset deals stand out for their return potential. According to recent research by PJT Partners, nearly two-thirds of secondaries investors (62%) are targeting net IRRs of 20% or more in the single-asset segment.3 In comparison, return thresholds for the multi-asset GP and LP-led segments are much lower, with only 40% and 16% of investors targeting returns as high as 20% or more, respectively.

Based on the fundamental performance and embedded value that we see in our own strategy, we believe that these investors’ expectations for single-asset deals are realistic and achievable for allocators deploying capital into the space today.

How does an allocation typically fit into an investor’s portfolio?
NW
: In our experience, investors typically see these deals fitting in a few different ways. First, they view single-asset secondaries as a definitive alpha source within private equity. They see the value of the prize assets being sold, which, when combined with their shorter duration and lower volatility characteristics, make for highly compelling investments. 

Second, to the extent that assets are sold out of portfolios into continuation funds, an allocation to a focused singleasset secondaries fund can capture value that an investor might otherwise have lost—i.e. as an investment, they can help to fill a gap left in the portfolio.

More generally, we would argue that the divergence that we’ve highlighted between LP and GP-led deals should be reflected in investors’ planning. That is to say that secondaries should not be thought of as a single bucket.

The two segments exhibit different risk and return characteristics and the simple fact that the GP-led market is now larger than the traditional LP-led segment suggests that a dedicated allocation to the sector warrants consideration.

These are complex investments. What skills are involved?
NW
: As with other differences discussed above, investment skillset is an area where LP and GP-led single-asset deals starkly diverge. The intricacies involved in sourcing, undertaking due diligence and executing on single-asset deals explain precisely why investors can earn a complexity premium in the space.

Below, we explain the steps that the Morgan Stanley Investment Management Private Markets Secondaries Team has taken in each of these areas to gain an edge.

SOURCING. We built a dedicated sourcing subgroup focused exclusively on deal origination. Our team members meet regularly with GPs to develop networks that will sustain a proprietary pipeline of the choicest opportunities. As incubation periods for a deals can last from three to 24 months, investing in these relationships has been critical to being a first port of call when GPs consider secondary sales.

The numbers bear this fact out. In our first portfolio, roughly 70% of our deals were either exclusive or proprietary. In our second portfolio, all transactions have been either exclusive or proprietary.

DUE DILIGENCE. Due diligence entails deep work in analyzing financial statements, understanding end markets and undertaking quality of earnings reports. We commission market studies and speak with customers, suppliers and industry experts to gain a real insight into the fundamentals of a given asset. As with sourcing, this requires a dedicated team, which we began building from the ground up in the advent of this market. 

DEAL EXECUTION. Single-asset deals involve an incredibly complex negotiation process that can take three to six months to conclude with a wide array of stakeholders. Success requires a specialized skillset to navigate potential conflicts, as transactions can include the GPs, rolling LP investors, selling LP investors as well as the new buyer group. We’ve transacted on 50 deals in this space, an amount not easily matched by our peers. From our perspective, this experience enables us to drive negotiations and become a preferred buyer for GPs.

In summary, the resource-intensive nature of this space creates barriers to entry that preclude “investor tourism.” Without a dedicated and expert team experienced in single-asset deal craft, investors will find success very difficult to achieve.

1 PJT Park Hill. “Secondary Roadmap Series.” Q1 2022.
2 Ibid.
3 Ibid.

 
nash.waterman
Head of AIP Private Markets Secondaries
AIP Private Markets Team
 
 
 
 

IMPORTANT INFORMATION

The statements above reflect the opinions and views of the Morgan Stanley Alternative Investment Partners Private Markets (“AIP Private Markets Team”) as of the date hereof and not as of any future date and will not be updated or supplemented. All forecasts are speculative, subject to change at any time and may not come to pass due to economic and market conditions.

By accepting this document, you agree that such document (including any data, analysis, conclusions or other information contained herein provided by the AIP Private Markets Team in connection herewith) may not be reproduced or otherwise shared or distributed to any other persons, in whole or in part, without the prior consent of an AIP Private Markets Team representative.

These comments are not necessarily representative of the opinions and views of any other Morgan Stanley portfolio manager or of Morgan Stanley as a whole. While the information contained herein is believed to be reliable, we cannot guarantee its accuracy or completeness. The recipient should bear in mind that past performance is not indicative of future results. Keep in mind that forecasts are inherently limited and should not be relied upon as an indicator of future performance. The views expressed are subject to change based on market, economic and other conditions. They should not be construed as recommendations, but as an illustration of broader economic themes.

Information regarding expected market returns and market outlooks is based on the research, analysis, and opinions of the investment team of the AIP Private Markets Team. These conclusions are speculative in nature, may not come to pass, and are not intended to predict the future of any specific Morgan Stanley investment.

Certain information contained herein constitutes forward-looking statements, which can be identified by the use of forward-looking terminology such as “may,” “will,” “should,” “expect,” “anticipate,” “project,” “estimate,” “intend,” continue” or “believe” or the negatives thereof or other variations thereon or other comparable terminology. Due to various risks and uncertainties, actual events or results may differ materially from those reflected or contemplated in such forward-looking statements. No representation or warranty is made as to future performance or such forward-looking statements.

There is no guarantee that any investment strategy will work under all market conditions, and each investor should evaluate their ability to invest for the long-term, especially during periods of downturn in the market. This piece has been prepared solely for informational purposes and is not an offer, or a solicitation of an offer, to buy or sell any security or instrument or to participate in any trading strategy. The material contained herein has not been based on a consideration of any individual recipient circumstances and is not investment advice, nor should it be construed in any way as tax, accounting, legal or regulatory advice. To that end, the recipient should seek independent legal and financial advice, including advice as to tax consequences, before making any investment decision. Any index referred to herein is the intellectual property (including registered trademarks) of the applicable licensor. Any product based on an index is in no way sponsored, endorsed, sold or respect thereto.

Persons considering an alternative investment should refer to the specific investment’s offering documentation, which will fully describe the specific risks and considerations associated with such investment.

Alternative investments typically have higher fees and expenses than other investment vehicles, and such fees and expenses will lower returns achieved by investors. Funds of funds often have a higher fee structure than single manager funds as a result of the additional layer of fees. Alternative investment funds are often unregulated, are not subject to the same regulatory requirements as mutual funds, and are not required to provide periodic pricing or valuation information to investors. The investment strategies described in the preceding pages may not be suitable for the recipient’s specific circumstances; accordingly, you should consult your own tax, legal or other advisors, both at the outset of any transaction and on an ongoing basis, to determine such suitability.

Risks Relating to Private Equity Investments. Certain funds will typically invest in securities, instruments and assets that are not, and are not expected to become, publicly traded and therefore may require a substantial length of time to realize a return or fully liquidate. The respective general partners cannot provide assurance that they will be able to identify, choose, make or realize investments of the type targeted for their fund, or that such fund will be able to invest fully its committed capital. There can be no assurance that a fund will be able to generate returns for its investors or that returns will be commensurate with the risks of the investments within such fund’s investment objectives. The business of identifying and structuring investments of the types contemplated by these funds is competitive and involves a high degree of uncertainty. In addition to competition from other investors, the availability of investment opportunities generally will be subject to market conditions as well as, in many cases, the prevailing regulatory or political climate. In addition, investments in infrastructure may be subject to a variety of legal risks, including environmental issues, land expropriation and other property-related claims, industrial action and legal action from special interest groups.

This is prepared for sophisticated investors who are capable of understanding the risks associated with the investments described herein and may not be appropriate for the recipient. No investment should be made without proper consideration of the risks and advice from your tax, accounting, legal or other advisors as you deem appropriate.

Morgan Stanley does not render tax advice on tax accounting matters to clients. This material was not intended or written to be used, and it cannot be used with any taxpayer, for the purpose of avoiding penalties which may be imposed on the taxpayer under U.S. federal tax laws. Federal and state tax laws are complex and constantly changing. Clients should always consult with a legal or tax advisor for information concerning their individual situation.

DISTRIBUTION

This communication is only intended for and will only be distributed to persons resident in jurisdictions where such distribution or availability would not be contrary to local laws or regulations.

United Kingdom: Morgan Stanley Investment Management Limited is authorised and regulated by the Financial Conduct Authority. Registered in England. Registered No. 1981121. Registered Office: 25 Cabot Square, Canary Wharf, London E14 4QA, authorised and regulated by the Financial Conduct Authority. Dubai: Morgan Stanley Investment Management Limited (Representative Office, Unit Precinct 3-7th Floor-Unit 701 and 702, Level 7, Gate Precinct Building 3, Dubai International Financial Centre, Dubai, 506501, United Arab Emirates. Telephone: +97 (0)14 709 7158). Germany: Morgan Stanley Investment Management Limited Niederlassung Deutschland Junghofstrasse 13-15 60311 Frankfurt Deutschland (Gattung: Zweigniederlassung (FDI) gem. § 53b KWG). Italy: Morgan Stanley Investment Management Limited, Milan Branch (Sede Secondaria di Milano) is a branch of Morgan Stanley Investment Management Limited, a company registered in the UK, authorised and regulated by the Financial Conduct Authority (FCA), and whose registered office is at 25 Cabot Square, Canary Wharf, London, E14 4QA. Morgan Stanley Investment Management Limited Milan Branch (Sede Secondaria di Milano) with seat in Palazzo Serbelloni Corso Venezia, 16 20121 Milano, Italy, is registered in Italy with company number and VAT number 08829360968. The Netherlands: Morgan Stanley Investment Management, Rembrandt Tower, 11th Floor Amstelplein 1 1096HA, Netherlands. Telephone: 31 2-0462-1300. Morgan Stanley Investment Management is a branch office of Morgan Stanley Investment Management Limited. Morgan Stanley Investment Management Limited is authorised and regulated by the Financial Conduct Authority in the United Kingdom. Switzerland: Morgan Stanley & Co. International plc, London, Zurich Branch Authorised and regulated by the Eidgenössische Finanzmarktaufsicht (“FINMA”). Registered with the Register of Commerce Zurich CHE-115.415.770. Registered Office: Beethovenstrasse 33, 8002 Zurich, Switzerland, Telephone +41 (0) 44 588 1000. Facsimile Fax: +41(0) 44 588 1074. Hong Kong: This document has been issued by Morgan Stanley Asia Limited for use in Hong Kong and shall only be made available to “professional investors” as defined under the Securities and Futures Ordinance of Hong Kong (Cap 571). The contents of this document have not been reviewed nor approved by any regulatory authority including the Securities and Futures Commission in Hong Kong. Accordingly, save where an exemption is available under the relevant law, this document shall not be issued, circulated, distributed, directed at, or made available to, the public in Hong Kong. Singapore: This document should not be considered to be the subject of an invitation for subscription or purchase, whether directly or indirectly, to the public or any member of the public in Singapore other than (i) to an institutional investor under section 304 of the Securities and Futures Act, Chapter 289 of Singapore (“SFA”), (ii) to a “relevant person” (which includes an accredited investor) pursuant to section 305 of the SFA, and such distribution is in accordance with the conditions specified in section 305 of the SFA; or (iii) otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA. In particular, for investment funds that are not authorized or recognized by the MAS, units in such funds are not allowed to be offered to the retail public; any written material issued to persons as aforementioned in connection with an offer is not a prospectus as defined in the SFA and, accordingly, statutory liability under the SFA in relation to the content of prospectuses does not apply, and investors should consider carefully whether the investment is suitable for them. Australia: This publication is disseminated in Australia by Morgan Stanley Investment Management (Australia) Pty Limited ACN: 122040037, AFSL No. 314182, which accept responsibility for its contents. This publication, and any access to it, is intended only for “wholesale clients” within the meaning of the Australian Corporations Act. Japan: For professional investors, this document is circulated or distributed for informational purposes only. For those who are not professional investors, this document is provided in relation to Morgan Stanley Investment Management (Japan) Co., Ltd. (“MSIMJ”)’s business with respect to discretionary investment management agreements (“IMA”) and investment advisory agreements (“IAA”). This is not for the purpose of a recommendation or solicitation of transactions or offers any particular financial instruments. Under an IMA, with respect to management of assets of a client, the client prescribes basic management policies in advance and commissions MSIMJ to make all investment decisions based on an analysis of the value, etc. of the securities, and MSIMJ accepts such commission. The client shall delegate to MSIMJ the authorities necessary for making investment. MSIMJ exercises the delegated authorities based on investment decisions of MSIMJ, and the client shall not make individual instructions. All investment profits and losses belong to the clients; principal is not guaranteed. Please consider the investment objectives and nature of risks before investing. As an investment advisory fee for an IAA or an IMA, the amount of assets subject to the contract multiplied by a certain rate (the upper limit is 2.16% per annum (including tax)) shall be incurred in proportion to the contract period. For some strategies, a contingency fee may be incurred in addition to the fee mentioned above. Indirect charges also may be incurred, such as brokerage commissions for incorporated securities. Since these charges and expenses are different depending on a contract and other factors, MSIMJ cannot present the rates, upper limits, etc. in advance. All clients should read the Documents Provided Prior to the Conclusion of a Contract carefully before executing an agreement. This document is disseminated in Japan by MSIMJ, Registered No. 410 (Director of Kanto Local Finance Bureau (Financial Instruments Firms)), Membership: the Japan Securities Dealers Association, The Investment Trusts Association, Japan, the Japan Investment Advisers Association and the Type II Financial Instruments Firms Association.

EMEA: This marketing communication has been issued by Morgan Stanley Investment Management Ireland Limited (“MSIM Ireland”). Authorised and regulated by the Financial Conduct Authority. Registered in England No. 1981121. Registered Office: 25 Cabot Square, Canary Wharf, London E14 4QA.

There is no guarantee that any investment strategy will work under all market conditions, and each investor should evaluate their ability to invest for the long-term, especially during periods of downturn in the market. Prior to investing, investors should carefully review the strategy’s/product’ relevant offering document. There are important differences in how the strategy is carried out in each of the investment vehicles.

MSIM Ireland has not authorised financial intermediaries to use and to distribute this document, unless such use and distribution is made in accordance with applicable law and regulation. Additionally, financial intermediaries are required to satisfy themselves that the information in this document is suitable for any person to whom they provide this document in view of that person’s circumstances and purpose. MSIM Ireland shall not be liable for, and accepts no liability for, the use or misuse of this document by any such financial intermediary.

CRC # 4619240 Exp. 4/6/2023

 

This is a Marketing Communication.

It is important that users read the Terms of Use before proceeding as it explains certain legal and regulatory restrictions applicable to the dissemination of information pertaining to Morgan Stanley Investment Management's investment products.

The services described on this website may not be available in all jurisdictions or to all persons. For further details, please see our Terms of Use.


Privacy & Cookies    •    Terms of Use

©  Morgan Stanley. All rights reserved.